5Li L,Chen J,Wang B,et al.Sera from patients with bullous pemphigoid (BP) associated with neurological diseases recognized BP antigen 1 in the skin and brain.Br J Dermatol,2009,160(6):1343-1345. 被引量：1
6Czernik A,Bystryn JC.Improvement of intravenous immunoglobulin therapy for bullous pemphigoid by adding immunosuppressive agents:marked improvement in depletion of circulating autoantibodies.Arch Dermatol,2008,144(5):658-661. 被引量：1
7Bernard P,Reguiai Z,Tancrède-Bohin E,et al.Risk factors for relapse in patients with bullous pemphigoid in clinical remission:a multicenter,prospective,cohort study.Arch Dermatol,2009,145(5):537-542. 被引量：1
8Joly P,Benichou J,Lok C,et al.Prediction of survival for patients with bullous pemphigoid:a prospective study.Arch Dermatol,2005,141(6):691-698. 被引量：1
9Yaneey KB. The pathophysiology of autoimmune blistering diseases[J]. J Clin Invest, 2005, 115(4): 825-828. 被引量：1
10Liu Z. Bullous pemphigoid: using animal models to study the immunopathology[J]. J Investig Dermatol Syrup Proc, 2004, 9(1): 41-46. 被引量：1
